English
Swedish
Finnish
Front page
Investors
Annual Reports
Dec 08, 2015 15:40
LinkedIn
Tweet
Facebook
2019
Oriola GRI supplement 2019.pdf
Oriola Financial Review 2019.pdf
Oriola Annual Review 2019.pdf
2018
Oriola Financial Review 2018.pdf
Oriola Annual Review 2018.pdf
2017
Oriola_annual_report_2017.pdf
2016
OriolaKD Annual Report 2016.pdf
2015
Oriola-KD Annual Review 2015.pdf
Report of the Board of Directors and Financial Statements 2015.pdf
2014
Oriola-KDs Annual Review 2014.pdf
Report of Board of Directors and Financial Statements 2014.pdf
2013
Report of the Board of Directors and Financial Statements 2013.pdf
2012
Report of the Board of Directors and Financial Statements 2012.pdf
2011
Report of the Board of Directors and Financial Statements 2011.pdf
2010
Financial Statements for 2010.pdf
Oriola-KD Årsredovisning 2010.pdf
Oriola-KD Corporation Annual Report 2010.pdf
Годовой отчет 2010.pdf
2009
Financial Statements for 2009.pdf
Oriola-KD Corporation Annual Report 2009.pdf
2008
Financial Statements for 2008.pdf
Oriola-KD Corporation Annual Report 2008.pdf
2007
Financial Statements for 2007.pdf
Oriola-KD Årsredovisning 2007.pdf
Oriola-KD Corporation Annual Report 2007.pdf
2006
Financial Statements for 2006.pdf
Oriola-KD Årsredovisning 2006 .pdf
Oriola-KD Corporation Annual Report 2006.pdf
NEXT:
Corporate Governance
English
Swedish
Finnish
Consumers
Pharmacies
Pharmacy Services
Brands
Pharmaceutical Companies
Expert services
Clinical services
Market and hospital access
Sales and marketing
Regulatory life cycle management
Real World Evidence
Patient support programs
Supply chain and logistics
Medicine importing services for a smooth solution
High-quality logistic services in the healthcare
Business Intelligence
Investors
Oriola as an Investment
Strategy and Targets
Key Figures
Operating environment
Acquisitions and Divestments
Analysts
Share information and Shareholders
Share Price Trends Tool
Total Return Calculator
Dividence Policy
Share Capital and Shares
Flagging Notifications
Consensus Estimates
Consensus Estimate chart
Conversion Right
Shareholders
Major Shareholders - shares
Major Shareholders - Votes
Silent Period
Financial Information
Key Figures
Long Term Targets
Latest Outlook
IFRS Principles
Investor Calendar
Investor Relations
Financial Reports
Q4 2019
Q3 2019
Q2 2019
Q1 2019
Q4 2018
Q3 2018
Q2 2018
Q1 2018
Q4 2017
Q3 2017
Q2 2017
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Annual Reports
Corporate Governance
Shareholder Meetings
AGM 2020
AGM 2019
AGM 2018
AGM 2017
AGM 2016
AGM 2015
AGM 2014
AGM 2013
AGM 2012
AGM 2011
Shareholders' Nomination Board
The Board of Directors
Diversity Policy
Members of the Board
Board Committees
President and CEO
Group Management Team
Remuneration Statement
External Audit
Internal Supervision and Internal Audit
Risks
Insider Register
Articles of Association
Shareholders' Agreements
Disclosure Policy
Corporate Governance Statement 2019
Media
Careers
Open Vacancies
About us
Sustainability
Sustainability strategy
Availability of pharmaceuticals
Regulatory compliance
Supply Chain Management
Tax footprint
Oriola as an employer
Diversity
Carbon footprint
Materiality Assessment
Energy
Waste
History
Management
Strategy
Contact
LinkedIn
Tweet
Facebook